Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland

Achim Berthele, Orhan Aktas, Ilya Ayzenberg, Heike Claus, Thiên-Trí Lâm, Wolfgang N. Löscher, Anne-Katrin Pröbstel, Harald Prüss, Nina Rademacher, Marius Ringelstein, Paulus Rommer, Ulrike Schara-Schmidt, Benedikt Schoser, Jörg R. Weber, Jana Zschüntzsch, Andreas Meisel, Jan D. Lünemann

Therapeutic Advances in Neurological Disorders

Published online on May 08, 2026

Abstract

Therapeutic Advances in Neurological Disorders, Volume 19, January-December 2026.
Inhibition of terminal complement activation is an effective therapeutic strategy for acetylcholine receptor antibody–positive generalized myasthenia gravis (gMG) and aquaporin-4 antibody–positive neuromyelitis optica spectrum disorder (NMOSD), but it ...